Release Date: 18/02/10 11:52 Summary: Half Yearly report and Accounts Price Sensitive: Yes Download Document 215.75KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%